Ongoing monitoring typically involves monthly or quarterly check-ins during dose titration, regular assessment of weight loss progress and tolerability, periodic lab work to monitor metabolic parameters, and screening for potential complications
Gorgojo-Martnez JJ, Serrano-Moreno C, Sanz-Velasco A, Feo-Ortega G, Almodvar-Ruiz F
In rare cases, GLP-1based therapies have been associated with pancreatitis, a serious condition involving inflammation of the pancreas
Products sold after opening or use, which have lost their integrity and resale value, are not subject to return or exchange unless they are inherently defective
Heart Protections Are Likely Reversed for a Few Reasons GLP-1 medications can support heart health in a few different ways